Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Xeljanz (tofacitnib) Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Xeljanz (tofacitnib) Drugmarket, defines the market attractiveness level of Xeljanz (tofacitnib) Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Xeljanz (tofacitnib) Drug industry, describes the types of Xeljanz (tofacitnib) Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Xeljanz (tofacitnib) Drug market and the development prospects and opportunities of Xeljanz (tofacitnib) Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Xeljanz (tofacitnib) Drug market in Chapter 13.
By Player:
Pfizer
By Type:
Tablets
Extended-release Tablets
By End-User:
Rheumatoid Arthritis
Psoriatic Arthritis
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Xeljanz (tofacitnib) Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Xeljanz (tofacitnib) Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Xeljanz (tofacitnib) Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Xeljanz (tofacitnib) Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Xeljanz (tofacitnib) Drug Market Analysis and Outlook to 2022
-
7.1 Global Xeljanz (tofacitnib) Drug Consumption (2017-2022)
-
7.2 United States Xeljanz (tofacitnib) Drug Consumption (2017-2022)
-
7.3 Europe Xeljanz (tofacitnib) Drug Consumption (2017-2022)
-
7.4 China Xeljanz (tofacitnib) Drug Consumption (2017-2022)
-
7.5 Japan Xeljanz (tofacitnib) Drug Consumption (2017-2022)
-
7.6 India Xeljanz (tofacitnib) Drug Consumption (2017-2022)
-
7.7 South Korea Xeljanz (tofacitnib) Drug Consumption (2017-2022)
8 Region and Country-wise Xeljanz (tofacitnib) Drug Market Analysis and Outlook to 2028
-
8.1 Global Xeljanz (tofacitnib) Drug Consumption Forecast (2022-2028)
-
8.2 United States Xeljanz (tofacitnib) Drug Consumption Forecast (2022-2028)
-
8.3 Europe Xeljanz (tofacitnib) Drug Consumption Forecast (2022-2028)
-
8.4 China Xeljanz (tofacitnib) Drug Consumption Forecast (2022-2028)
-
8.5 Japan Xeljanz (tofacitnib) Drug Consumption Forecast (2022-2028)
-
8.6 India Xeljanz (tofacitnib) Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Xeljanz (tofacitnib) Drug Consumption Forecast (2022-2028)
9 Global Xeljanz (tofacitnib) Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Xeljanz (tofacitnib) Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Extended-release Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Xeljanz (tofacitnib) Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Xeljanz (tofacitnib) Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Xeljanz (tofacitnib) Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Extended-release Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Xeljanz (tofacitnib) Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Xeljanz (tofacitnib) Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Xeljanz (tofacitnib) Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Xeljanz (tofacitnib) Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Xeljanz (tofacitnib) Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Xeljanz (tofacitnib) Drug Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Xeljanz (tofacitnib) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Xeljanz (tofacitnib) Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Xeljanz (tofacitnib) Drug
-
Figure Xeljanz (tofacitnib) Drug Picture
-
Table Global Xeljanz (tofacitnib) Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Xeljanz (tofacitnib) Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Xeljanz (tofacitnib) Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Xeljanz (tofacitnib) Drug Consumption by Country (2017-2022)
-
Figure United States Xeljanz (tofacitnib) Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Xeljanz (tofacitnib) Drug Consumption and Growth Rate (2017-2022)
-
Figure China Xeljanz (tofacitnib) Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Xeljanz (tofacitnib) Drug Consumption and Growth Rate (2017-2022)
-
Figure India Xeljanz (tofacitnib) Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Xeljanz (tofacitnib) Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Xeljanz (tofacitnib) Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Xeljanz (tofacitnib) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Xeljanz (tofacitnib) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Xeljanz (tofacitnib) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Xeljanz (tofacitnib) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Xeljanz (tofacitnib) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Xeljanz (tofacitnib) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Extended-release Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriatic Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Extended-release Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriatic Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Xeljanz (tofacitnib) Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Xeljanz (tofacitnib) Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Xeljanz (tofacitnib) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Xeljanz (tofacitnib) Drug Product and Service
-
